Our CEO, Russ Tucker, headed to The Churchill War Rooms this week. A unique location with a specific challenge from Government to all attendees: what infrastructure should the UK build to enable to scale-up of industrial biotech solutions?
Joining other company leaders, policy experts and academics, Russ participated in discussions to identify where the UK needs to Own vs. Collaborate vs. Access.
With £184M of funding announced for engineering biology infrastructure, it was exciting to see the depth of research the GO Science Policy team were undertaking to get the best possible outcome. We look forward to seeing the insights put into action!